JP2019513769A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019513769A5 JP2019513769A5 JP2018553392A JP2018553392A JP2019513769A5 JP 2019513769 A5 JP2019513769 A5 JP 2019513769A5 JP 2018553392 A JP2018553392 A JP 2018553392A JP 2018553392 A JP2018553392 A JP 2018553392A JP 2019513769 A5 JP2019513769 A5 JP 2019513769A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- mucosa
- strain
- composition according
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 20
- 241001227620 Roseomonas mucosa Species 0.000 claims 8
- 210000004877 mucosa Anatomy 0.000 claims 7
- 206010012438 Dermatitis atopic Diseases 0.000 claims 6
- 201000008937 atopic dermatitis Diseases 0.000 claims 6
- 239000003937 drug carrier Substances 0.000 claims 5
- 239000002674 ointment Substances 0.000 claims 4
- 239000007788 liquid Substances 0.000 claims 3
- 229930006000 Sucrose Natural products 0.000 claims 2
- 230000001332 colony forming effect Effects 0.000 claims 2
- 239000006071 cream Substances 0.000 claims 2
- 239000006260 foam Substances 0.000 claims 2
- 239000000499 gel Substances 0.000 claims 2
- 239000005720 sucrose Substances 0.000 claims 2
- 239000006208 topical dosage form Substances 0.000 claims 2
- 241000191967 Staphylococcus aureus Species 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 125000000185 sucrose group Chemical group 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662324762P | 2016-04-19 | 2016-04-19 | |
| US62/324,762 | 2016-04-19 | ||
| PCT/US2017/028133 WO2017184601A1 (en) | 2016-04-19 | 2017-04-18 | Use of gram negative species to treat atopic dermatitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019513769A JP2019513769A (ja) | 2019-05-30 |
| JP2019513769A5 true JP2019513769A5 (enExample) | 2020-05-21 |
Family
ID=58708000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018553392A Pending JP2019513769A (ja) | 2016-04-19 | 2017-04-18 | アトピー性皮膚炎を処置するためのグラム陰性種の使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (8) | US10195236B2 (enExample) |
| EP (2) | EP3903766A1 (enExample) |
| JP (1) | JP2019513769A (enExample) |
| KR (1) | KR102340006B1 (enExample) |
| CN (1) | CN109310626A (enExample) |
| AU (2) | AU2017253935B2 (enExample) |
| CA (1) | CA3020863A1 (enExample) |
| IL (1) | IL262455A (enExample) |
| MX (1) | MX2018012719A (enExample) |
| SG (1) | SG11201809100QA (enExample) |
| WO (1) | WO2017184601A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6494233B2 (ja) * | 2013-10-03 | 2019-04-03 | 日東電工株式会社 | 粘膜ワクチン組成物 |
| CN115919906A (zh) | 2016-03-04 | 2023-04-07 | 加利福尼亚大学董事会 | 微生物聚生体及其用途 |
| US10293005B2 (en) | 2016-04-19 | 2019-05-21 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Use of gram negative species to treat atopic dermatitis |
| KR102340006B1 (ko) | 2016-04-19 | 2021-12-20 | 더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 | 아토피 피부염을 치료하기 위한 그램 음성 종의 용도 |
| JP7460531B2 (ja) | 2017-12-05 | 2024-04-02 | バイオピーエルエックス，インコーポレイティド | 微生物感染を防ぐための方法および組成物 |
| EP3773645A4 (en) * | 2018-04-10 | 2021-11-24 | Siolta Therapeutics, Inc. | MICROBIAL CONSORTIA |
| MX2020011016A (es) * | 2018-04-18 | 2021-01-29 | Forte Subsidiary Inc | Composiciones para el tratamiento de condiciones de la piel. |
| JP2021523900A (ja) * | 2018-05-11 | 2021-09-09 | フォルテ サブシディアリー，インク． | 皮膚疾病の処置のための組成物 |
| EP3826653A4 (en) * | 2018-07-23 | 2022-03-23 | The United States of America, as represented by the Secretary, Department of Health and Human Services | Use of gram negative species to treat atopic dermatitis |
| KR102691627B1 (ko) | 2022-04-19 | 2024-08-06 | 코스맥스 주식회사 | 로제오모나스 뮤코사 균주 및 그의 피부 상태 개선 용도 |
| KR102691625B1 (ko) | 2022-04-19 | 2024-08-06 | 코스맥스 주식회사 | 세디미니박테리움 락티스 균주 및 그의 피부 상태 개선 용도 |
| CN115140846B (zh) * | 2022-07-06 | 2024-06-21 | 江苏聚庚科技股份有限公司 | 一种复合处理剂、制备方法及其在净化废水中的应用 |
| CN116139163B (zh) * | 2023-03-22 | 2023-09-05 | 中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所) | 一种粘液玫瑰单胞菌胞外多糖在制备用于缓解特应性皮炎的药物上的应用 |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1019523A (en) | 1910-03-14 | 1912-03-05 | Maxmillian E Primbs | Ironing-table. |
| US1020695A (en) | 1911-11-17 | 1912-03-19 | Hess Mfg Co | Drier. |
| US3854480A (en) | 1969-04-01 | 1974-12-17 | Alza Corp | Drug-delivery system |
| US3832253A (en) | 1973-03-21 | 1974-08-27 | Baxter Laboratories Inc | Method of making an inflatable balloon catheter |
| US4667014A (en) | 1983-03-07 | 1987-05-19 | Syntex (U.S.A.) Inc. | Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists |
| US4452775A (en) | 1982-12-03 | 1984-06-05 | Syntex (U.S.A.) Inc. | Cholesterol matrix delivery system for sustained release of macromolecules |
| CA1200416A (en) | 1983-05-13 | 1986-02-11 | Societe Des Produits Nestle S.A. | Food process |
| US4829000A (en) | 1985-08-30 | 1989-05-09 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Reconstituted basement membrane complex with biological activity |
| JPH04167172A (ja) | 1990-10-31 | 1992-06-15 | Nec Corp | ベクトルプロセッサ |
| ES2157996T3 (es) | 1993-10-22 | 2001-09-01 | Smithkline Beecham Corp | Nueva composicion. |
| US6645506B1 (en) * | 1997-04-18 | 2003-11-11 | Ganeden Biotech, Inc. | Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil |
| EP1067956B1 (en) | 1998-04-03 | 2007-03-14 | University Of Iowa Research Foundation | Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
| US6974585B2 (en) | 2001-08-01 | 2005-12-13 | Medlogic Global Limited | Durable multi-component antibiotic formulation for topical use |
| US20030100034A1 (en) | 2001-10-16 | 2003-05-29 | Millennium Pharmaceuticals, Inc. | 9136, a human aldehyde dehydrogenase family member and uses therefor |
| DE10158712A1 (de) | 2001-11-29 | 2003-06-26 | Umwelttechnik Georg Fritzmeier | Zusammensetzung zur Behandlung der Hautoberfläche |
| KR100536522B1 (ko) * | 2003-03-07 | 2005-12-14 | (주)바이오솔루션 | 인간 피부 유래의 신규한 박테리오신 및 여드름치료제로서의 용도 |
| EP1786445B1 (en) * | 2004-08-25 | 2011-06-08 | The Government of the United States of America as represented by The Secretary of the Department of Health and Human Services | Live microbial microbicides |
| JP2006131622A (ja) | 2004-10-05 | 2006-05-25 | Genichiro Soma | 薬剤 |
| KR20070091613A (ko) | 2004-11-08 | 2007-09-11 | 그렌마크 파머수티칼스 엘티디. | 항여드름 화합물 및 항생제 화합물을 함유하는 국소적 제약조성물 |
| EP1736537A1 (en) | 2005-06-22 | 2006-12-27 | OrganoBalance GmbH | Methods and means for protecting the skin against pathogenic microorganisms |
| FR2942719B1 (fr) | 2009-03-04 | 2011-08-19 | Oreal | Utilisation de microorganismes probiotiques pour limiter les irritations cutanees |
| PL2448577T3 (pl) | 2009-06-30 | 2017-02-28 | Derman Biomedicine Co. Ltd. | Kompozycje zawierające berberynę lub jej analogi do leczenia trądziku różowatego lub chorób skóry związanych z zaczerwienieniem twarzy |
| US9050319B2 (en) | 2010-04-30 | 2015-06-09 | Telormedix, Sa | Phospholipid drug analogs |
| PL2704704T3 (pl) | 2011-05-03 | 2019-04-30 | Dupont Nutrition Biosci Aps | Bakterie probiotyczne do miejscowego leczenia zaburzeń skóry |
| US20130121968A1 (en) | 2011-10-03 | 2013-05-16 | Atossa Genetics, Inc. | Methods of combining metagenome and the metatranscriptome in multiplex profiles |
| BR112014021388A2 (pt) | 2012-02-29 | 2017-07-18 | Ethicon Endo Surgery Inc | composições de microbiota e métodos rela-cionados às mesmas |
| GB201206599D0 (en) | 2012-04-13 | 2012-05-30 | Univ Manchester | Probiotic bacteria |
| WO2014112196A1 (ja) | 2013-01-15 | 2014-07-24 | 日本精工株式会社 | チルト式ステアリング装置 |
| US9956282B2 (en) | 2013-12-16 | 2018-05-01 | Seres Therapeutics, Inc. | Bacterial compositions and methods of use thereof for treatment of immune system disorders |
| JP2017519486A (ja) | 2014-04-15 | 2017-07-20 | エーオーバイオーム， エルエルシー．ＡＯＢｉｏｍｅ， ＬＬＣ． | アンモニア酸化Ｎｉｔｒｏｓｏｍｏｎａｓ ｅｕｔｒｏｐｈａ株Ｄ２３ |
| MA41020A (fr) | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
| US9526201B2 (en) | 2015-01-05 | 2016-12-27 | Cnh Industrial America Llc | Twin-row planter with tandem driven seed meters |
| US10774305B2 (en) | 2015-04-20 | 2020-09-15 | S-Biomedic Nv | Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains |
| KR102340006B1 (ko) | 2016-04-19 | 2021-12-20 | 더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 | 아토피 피부염을 치료하기 위한 그램 음성 종의 용도 |
| US10293005B2 (en) | 2016-04-19 | 2019-05-21 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Use of gram negative species to treat atopic dermatitis |
| US10695386B2 (en) | 2017-05-11 | 2020-06-30 | Shayne K. Morris | Skin microbiome colonizer formulations and methods for use |
| MX2020011016A (es) | 2018-04-18 | 2021-01-29 | Forte Subsidiary Inc | Composiciones para el tratamiento de condiciones de la piel. |
| JP2021523900A (ja) | 2018-05-11 | 2021-09-09 | フォルテ サブシディアリー，インク． | 皮膚疾病の処置のための組成物 |
| EP3826653A4 (en) | 2018-07-23 | 2022-03-23 | The United States of America, as represented by the Secretary, Department of Health and Human Services | Use of gram negative species to treat atopic dermatitis |
-
2017
- 2017-04-18 KR KR1020187033500A patent/KR102340006B1/ko not_active Expired - Fee Related
- 2017-04-18 CN CN201780038148.6A patent/CN109310626A/zh active Pending
- 2017-04-18 JP JP2018553392A patent/JP2019513769A/ja active Pending
- 2017-04-18 EP EP21180582.5A patent/EP3903766A1/en not_active Withdrawn
- 2017-04-18 SG SG11201809100QA patent/SG11201809100QA/en unknown
- 2017-04-18 MX MX2018012719A patent/MX2018012719A/es unknown
- 2017-04-18 CA CA3020863A patent/CA3020863A1/en not_active Abandoned
- 2017-04-18 EP EP17723547.0A patent/EP3445330B1/en active Active
- 2017-04-18 WO PCT/US2017/028133 patent/WO2017184601A1/en not_active Ceased
- 2017-04-18 AU AU2017253935A patent/AU2017253935B2/en not_active Ceased
-
2018
- 2018-03-28 US US15/939,066 patent/US10195236B2/en active Active
- 2018-06-21 US US16/014,971 patent/US10206957B2/en not_active Expired - Fee Related
- 2018-10-18 IL IL262455A patent/IL262455A/en unknown
- 2018-11-08 US US16/184,498 patent/US20190076486A1/en not_active Abandoned
-
2019
- 2019-01-10 US US16/244,903 patent/US20190142873A1/en not_active Abandoned
- 2019-01-16 US US16/249,721 patent/US10682379B2/en not_active Expired - Fee Related
- 2019-02-28 US US16/288,630 patent/US10946048B2/en not_active Expired - Fee Related
- 2019-07-25 US US16/522,357 patent/US10980846B2/en not_active Expired - Fee Related
- 2019-07-25 US US16/522,333 patent/US10946049B2/en not_active Expired - Fee Related
-
2021
- 2021-08-10 AU AU2021215132A patent/AU2021215132A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019513769A5 (enExample) | ||
| BR112018001811A2 (pt) | composição de bactérias láticas para uso no tratamento de infecções devidas a pro-pionibacterium acnes e em particular para acne | |
| CA3006294A1 (en) | Combinations of rapamycin and metformin for the treatment of joint and skin diseases | |
| WO2015066647A3 (en) | Ionic liquids for transdermal drug delivery | |
| JP6429131B2 (ja) | 膣症を予防および治療するために塩および糖を有効成分として含む皮膚外用組成物およびその使用 | |
| JP2016507532A5 (enExample) | ||
| PH12020500543A1 (en) | Nonracemic mixtures and uses thereof | |
| RU2014142038A (ru) | Короткие антимикробные липопептиды | |
| CN111836877A (zh) | 抗菌防腐剂组合物 | |
| MX2022001736A (es) | Formulaciones y tratamientos topicos. | |
| GB2593281A (en) | Use of gram negative species to treat atopic dermatitis | |
| WO2016063265A3 (pt) | Formulação tópica para o tratamento de infeções na pele ou mucosas, método de preparação e seus usos | |
| CN102824337A (zh) | 一种治疗家畜子宫内膜炎的凝胶剂及其制备方法 | |
| US20110171326A1 (en) | Pharmaceutical material for psoriasis treatment | |
| CN103948607A (zh) | 杀菌抑菌冻疮膏 | |
| CN106902133A (zh) | 一种治疗皮肤病的药物 | |
| Yadav et al. | Management of Burn in Bovines-A Clinical Study. | |
| Fanting et al. | Pharmacodynamic study of different formulations of gynecological ice snake | |
| RU2020102673A (ru) | Антибактериальная активность галактоолигосахарида и ксилита в дерматологических лечениях | |
| Kashcheyeva et al. | Prospects for the use of bacteriophages in cosmetology for the prevention of skin diseases | |
| Verkhovodova | In vitro study of antimicrobal activity of some salvia officinalis extracts | |
| Schneider et al. | Infectious Disease | |
| Starzhinskaya et al. | Improvement of extemporaneous ointment with wound healing action | |
| CN104604960A (zh) | 一种复方辣椒碱消毒剂 | |
| CN105078951A (zh) | 杏仁酸在抑制痤疮杆菌中的用途 |